Search

Search Constraints

You searched for: Author/Creator Isobe, Hiroshi

Search Results

1. A Phase II Study of Amrubicin as a Third‐Line or Fourth‐Line Chemotherapy for Patients With Non‐Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901. (26th February 2013)

2. A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302). (December 2019)

3. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702). (8th May 2019)

4. Cerium oxide (CeO2-x) nanoparticles with high Ce3+ proportion synthesized by pulsed plasma in liquid. Issue 17 (1st December 2020)

5. Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression. (3rd July 2018)

6. Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004). (March 2021)

7. Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival. Issue 7 (July 2020)

8. Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer. Issue 5 (26th April 2017)

9. Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation. Issue 2 (May 2015)

10. Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies. (6th October 2020)